Objectives. We determined rates of prenatal HIV testing and investigated ba
rriers to testing.
Methods. We surveyed 1362 representative parturient women from 7 hospitals
in 4 locations of the United States.
Results. Overall, 89.9% of women reported being offered HIV testing and 69.
6% reported being tested. Proportions of women not offered testing differed
by location (range= 5.2%-16.3%), as did proportions not tested (range= 12.
2%-54.4%). Among women who perceived that their clinicians had not recommen
ded testing, 41.7% were tested, compared with 92.8% of women who perceived
a strong recommendation (P < .05). Private insurance for prenatal care was
also associated with not being tested. Women gave multiple reasons for not
being tested, most commonly not being at risk, having been tested recently,
and the test's not being offered or recommended, cited by 55.3%, 39.1% and
11.1% of women, respectively.
Conclusions. Although most parturient women were offered a prenatal HIV tes
t and got tested, testing proportions did not reach national goals and diff
ered significantly by location and payment-status. Concern about testing co
nsequences was not a major barrier. Perception of clinicians' recommendatio
ns strongly influenced testing. Changing provider practices will be essenti
al to implementing universal prenatal HIV testing.